AP Healthcare Inc.

A109960

KR7109960005

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
599 ^KRW	-0.66%		-2.28%	-23.11%

Mar. 13	Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Aprogen Healthcare & Games Inc. announced that it has received KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	CI

Aprogen Healthcare & Games Inc. announced that it has received KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.

December 18, 2023

On December 19, 2023, Aprogen Healthcare & Games Inc. closed the transaction.

Latest news about AP Healthcare Inc.

Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Aprogen Healthcare & Games Inc. announced that it has received KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	Dec. 18	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Aprogen Healthcare & Games Inc. announced that it has received KRW 20.000001189 billion in funding	23-04-25	CI
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 20.000001189 billion in funding	23-04-17	CI
Aprogen Healthcare & Games Inc. acquired an 89.86% stake in Aprogen, Inc. for KRW 2.2 billion.	22-12-28	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-14	CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.	21-09-15	CI
Osung Advanced Materials Co., Ltd. cancelled the acquisition of an additional 3.5% stake in S-MAC CO., Ltd. from Aprogen Healthcare & Games Inc..	21-01-05	CI
Aprogen KIC Inc. cancelled the acquisition of Aprogen Healthcare & Games Inc..	20-09-07	CI
An unknown buyer completed the acquisition of 7.9% stake in Aprogen Healthcare & Games Inc. from S-MAC CO., Ltd..	20-04-27	CI
Aprogen KIC Inc. agreed to acquire Aprogen Healthcare & Games Inc. for approximately KRW 140 billion.	20-04-23	CI
Hangul Aprogen Co., Ltd. agreed to acquire 7.1% stake in S-MAC CO., Ltd. from Aprogen Healthcare & Games Inc..	20-04-07	CI
YJ Fund 3 and Alberge Fund completed the acquisition of 8.6% in S-MAC CO., Ltd. from Aprogen Healthcare & Games Inc..	20-04-07	CI
Osung Advanced Materials Co., Ltd. agreed to acquire an additional 3.5% stake in S-MAC CO., Ltd. from Aprogen Healthcare & Games Inc. for KRW 10 billion.	20-01-05	CI
YJ Fund 3 and Alberge Fund agreed to acquire 8.6% in S-MAC CO., Ltd. from Locojoy International Corporation for KRW 20 billion.	19-11-20	CI
Aprogen pharmaceuticals,Inc. acquired an additional 6.38% stake in Locojoy International Corporation from Aprogen Biologics Inc. for KRW 7 billion.	19-09-29	CI
Aprogen KIC Inc. announced that it has received KRW 70 billion in funding from Locojoy International Corporation	18-09-13	CI
Aprogen KIC Inc. announced that it expects to receive KRW 70 billion in funding from Locojoy International Corporation	18-09-12	CI

Aprogen Healthcare & Games Inc is a Korea-based company engaged in the manufacture and sale of pharmaceutical products. The Company mainly operates in four business segments. The Pharmaceutical segment provides medicines for digestive system, integumentary, nutrients and tonics and antibiotic preparations. The Insulation segment provides insulation products for refineries and other plants. The Rental segment provides office and laboratory rental services. The Other segment mainly provides business support services.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AP HEALTHCARE INC.	-23.11%	49.66M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B